Screening for Abdominal Aortic Aneurysm in 65 Year Old Males in Oslo

Male subjects, 65 years of age, living in Oslo, Norway will be invited to be screened for abdominal aortic aneurysm.

Enrolling by Invitation

Interested in participating?

Key information

Conditions

Abdominal Aortic Aneurysm Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal Aortic Diseases Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Cardiovascular Diseases Vascular Diseases

Age range

65 year–65 year

Sex eligibility

Male

Study type

Observational

About this study

The invited population will be offered ultrasound investigation of their abdominal aorta. Further information regarding risk factors will be noted and measurement of ankle-brachial index will be measured/calculated. A further step in the future will be to sample blood with focus on different cytokines and genmediators.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Males aged 65 years

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Abdominal Aortic Aneurysm (AAA)

Time frame: Yearly the number of patients with AAA among the screened population will be assessed during the inclusion period of 18 years..

AAA definition: diameter equal or more than 30 mm. The number of identified patients with AAA will be yearlig assessed.

Secondary outcomes

Peripheral Arterial Disease (PAD)

Time frame: Yearly the number of patients with PAD among the screened poplulation will be assessed during the inclusion period of 18 years.

Investigate the prevalence of PAD among patients with AAA defined as having Ankle-Arm Index (AAI) less than 0.9. The number of these patients will be assessed yearly.

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Official study title

Screening for Abdominal Aortic Aneurysm

Acronym: AAAscreening

Important dates

Study start: 2011
Primary completion: 2029
Study completion: 2029
First posted: Nov 25, 2010
Registry last updated: Mar 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed